These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11377569)

  • 21. Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
    Fritsche L; Sperschneider H; Budde K; Giessing M; Türk H; Böhler T; Schröder K; Stein G; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2229. PubMed ID: 9723451
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.
    Miladipour AH; Ghods AJ; Nejadgashti H
    Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
    Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
    [No Abstract]   [Full Text] [Related]  

  • 24. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract]   [Full Text] [Related]  

  • 25. Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients.
    Fritsche L; Sperschneider H; Budde K; Giessing M; Morgera S; Schröder K; Stein G; Neumayer HH
    Transplant Proc; 1998 Jun; 30(4):1190-1. PubMed ID: 9636481
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E; Remport A; Járay J; Máthé Z; Borka P; Perner F
    Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract]   [Full Text] [Related]  

  • 27. Infection of beta-herpesviruses (CMV, HHV-6, HHV-7): role in postrenal transplantation complications.
    Chapenko S; Folkmane I; Tomsone V; Kozireva S; Bicans J; Amerika D; Rozentals R; Murovska M
    Transplant Proc; 2001 Jun; 33(4):2463-4. PubMed ID: 11406212
    [No Abstract]   [Full Text] [Related]  

  • 28. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
    Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
    Jirasiritham S; Sumethkul V; Mavichak V; Chalermsanyakorn P
    Transplant Proc; 2000 Nov; 32(7):2040-2. PubMed ID: 11120057
    [No Abstract]   [Full Text] [Related]  

  • 30. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF; Górriz JL; Sancho A; Avila A; Alcoy E; Pallardó LM
    Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
    Liu B; Lin ZB; Ming CS; Zhang WJ; Chen ZS; Sha B; Zeng FJ; Chen S
    Transplant Proc; 2003 Feb; 35(1):87-8. PubMed ID: 12591319
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
    Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
    Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
    [No Abstract]   [Full Text] [Related]  

  • 33. Ureteritis due to cytomegalovirus infection in renal transplant recipient: a case report.
    Vongwiwatana A; Vareesangthip K; Vasuvattakul S; Prommol S; Nualyong C; Parichatikanond P; Ong-Aj-Yooth L; Nimmannit S
    Transplant Proc; 2000 Nov; 32(7):1927. PubMed ID: 11120004
    [No Abstract]   [Full Text] [Related]  

  • 34. Mycophenolate mofetil in living donor renal allograft recipients.
    Park K; Moon JI; Kim SI; Kim YS
    Transplant Proc; 1999; 31(1-2):1133. PubMed ID: 10083506
    [No Abstract]   [Full Text] [Related]  

  • 35. Tolerability of mycophenolate mofetil in organ transplant recipients.
    Schweizer RT; Meisterling LD
    Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
    [No Abstract]   [Full Text] [Related]  

  • 36. Progress with cyclosporine-sparing regimens.
    Grinyó JM
    Transplant Proc; 1999 Dec; 31(8A):11S-16S. PubMed ID: 10616555
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients.
    Kliem V; Boeck A; Eisenberger U; Petersen R; Radermacher J; Hiss M; Pethig M; Koch KM; Nashan B; Brunkhorst R
    Transplant Proc; 1999; 31(1-2):1312-3. PubMed ID: 10083586
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
    Conti DJ; Isenberg A; Shen GK; Hahn A; Singh TP
    Transplant Proc; 1998 Jun; 30(4):1314-5. PubMed ID: 9636533
    [No Abstract]   [Full Text] [Related]  

  • 40. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
    Cubas A; Herrero JC; Morales E; Carreño A; Dominguez-Gil B; Cirujeda A; Praga M; Ortuño T; Hernandez E; Delgado M; Andres A; Morales JM
    Transplant Proc; 1999 Sep; 31(6):2265-6. PubMed ID: 10500570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.